Real-world treatment for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: information from a Japanese hospital claims database
Recent actual drug use in Japan has been aligning increasingly closely with the EULAR recommendations.
Authors
- Takashi Funatogawa
- Kazuma Mii
- Kazuki Kojima (ORCID: https://orcid.org/0000-0003-2263-9609)
- Yuka Aoki
- Yoichi Matsubara (ORCID: https://orcid.org/0000-0001-5990-8214)
- Mariko Hoshiba
Institutions
- Chugai Pharma (United States) (US)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1093/mr/roaf082
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chugai Pharmaceutical